Future studies are needed to further clarify the clinical advantages of GIPR/GLP-1R dual agonists beyond weight loss
Neurodegeneration and AD models: exenatide Considering the successful neuroprotection of GLP-1RAs in in vivo diabetic models, researchers have directly tested GLP-1RAs in in vivo models of neurodegenerative diseases, including toxin-induced and transgenic models
In the present study, rat model of TLE was induced by intrahippocampal kainate and animals received ALC (100 mg/kg, p.o
Researchers who purchase retatrutide before their freezer space, reconstitution supplies, and protocol timeline are organized often end up storing product under suboptimal conditions
Chronic kidney disease in type 1 diabetes: translation of novel type 2 diabetes therapeutics to individuals with type 1 diabetes
What is Glutathione and How Does it Work